Daily as of 3 Nov 16:00 ET
- Price
- below both $7.71 vs 50 $10.78 / 200 $9.51
- Projection
- 💀Death cross projected in 11 bars
- Test
- No active test
- Last cross
- 🟨Golden cross 2 Jun 2025 · projected 25 bars out · tested 1 bar
IMMX | Immix BiopharmaNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$7.71
+$0.45 (+6.20%)
Immix Biopharma (IMMX) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2023.
Right now the daily is the chart to watch. The 50 SMA has sat above the 200 since Jun 2025, but the two have been closing on each other and a death cross is projected within 20 bars. On both the daily and the 4-hour, price sits below the 50 and the 200; on the weekly it is between the two.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- between the two $7.68 vs 50 $8.70 / 200 $4.09
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross week of 8 Dec 2025 · projected 7 bars out
4-hour as of 3 Nov 16:00 ET
- Price
- below both $7.71 vs 50 $8.75 / 200 $10.44
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 19 Oct 2026 · projected 29 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 19 Oct 2026 | 💀Death | 4-hour | 29 bars out | Not tested |
| 7 Jul 2026 | 🟨Golden | 4-hour | 27 bars out | Not tested |
| 22 Jun 2026 | 💀Death | 4-hour | 21 bars out | 1 bar cross test |
| week of 8 Dec 2025 | 🟨Golden moderate | weekly | 7 bars out | Not tested |
| 23 Oct 2025 | 🟨Golden | 4-hour | 28 bars out | Not tested |
About IMMX
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$14.8M
4-hour coverageYes, since Oct 2025
History on recordSince 2023
SectorHealthcare
Cap bandsmall